NCT02033031View on ClinicalTrials.gov

Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

February 28, 2013

Conditions
Branch Retinal Vein Occlusion
Interventions
DRUG

Lucentis intravitreal injection

Lucentis intravitreal injection

DRUG

Avastin intravitreal injection

Avastin intravitreal injection

Trial Locations (1)

Unknown

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT02033031 - Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion | Biotech Hunter | Biotech Hunter